Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Other Publications
    • ajnr

User menu

  • Subscribe
  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

  • Subscribe
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Publication Preview--Ahead of Print
    • Past Issue Archive
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • For Authors
  • About Us
    • About AJNR
    • Editors
    • American Society of Neuroradiology
  • Submit a Manuscript
  • Podcasts
    • Subscribe on iTunes
    • Subscribe on Stitcher
  • More
    • Subscribers
    • Permissions
    • Advertisers
    • Alerts
    • Feedback
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds
LetterLetter

Thallium-201 Single-Photon Emission CT in Recurrent Squamous Cell Carcinoma of the Head and Neck

Lorcan A. O’Tuama and Tina Young Poussaint
American Journal of Neuroradiology January 2002, 23 (1) 174-175;
Lorcan A. O’Tuama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Young Poussaint
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
Loading

We read with interest the report by Mukherji et al (1) concerning the use of thallium-201 single-photon emission CT to detect primary squamous cell carcinoma of the head and neck. The authors clearly show that high accuracy is obtained for thallium-201 single-photon emission CT in the differential diagnosis of recurrent tumor versus treatment effect in this tumor group, surpassing the reliability of CT in detecting this problem. We bring to the attention of your readers our work (2), which suggests another potentially important area of diagnostic benefit from thallium-201, specifically the ability to obtain prognostic information concerning the expected biological aggressivity of a childhood brain tumor. Abnormal thallium-201 uptake in this population appeared to denote a subgroup of lesions with distinctly greater mortality and morbidity. Thallium-201-avid lesions showed a 50% shorter period of recurrence-free survival from the time of diagnosis (P < .01). These findings exceeded the specificity of correlated structural imaging, mainly MR imaging. It would be of interest to know whether Dr. Mukherji and colleagues found any similar trends with respect to the different groups of cancer of the head and neck.

Both the University of North Carolina and our study thus suggest that the widely available and relatively inexpensive agent, thallium-201, provides important functional information regarding the biological behavior of brain tumors, which cannot generally be gleaned from the structural imaging findings alone. If confirmed in further clinical experience, this information has great potential benefit and may influence patient counseling regarding long-term outcome and be useful in the selection of the best treatment protocols.

References

  1. ↵
    Mukherji SK, Gapany M, Phillips D, et al. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1999;20:1215–1220
    Abstract/FREE Full Text
  2. ↵
    O’Tuama LA, Poussaint TY, Anthony DC, Treves ST. Childhood brain tumor: neuroimaging correlated with disease outcome. Pediatr Neurol 1998;19:259–262
    PubMed

Reply

We thank Drs. O’Tuama and Poussaint for their interest in our work (1). Our study group consisted of patients with recurrent tumors and not primary neoplasms. Thus, we did not have the ability to investigate the prognostic capability of thallium-201 before treatment. It would have been difficult to draw any such conclusions from our patient population, because we evaluated previously treated patients for recurrent disease and the effect of thallium uptake after various forms of treatment had not been sufficiently investigated.

Drs. O’Tuama and Poussaint raise a potentially important use of thallium with respect to predicting treatment response and potentially stratifying treatment regimens on the basis of objective quantitative criteria. I would call their attention to the work of Nagamachi et al (2, 3). This group performed a semiquantitative measurement of thallium-201 to predict the response of squamous cell carcinoma of the head and neck to radiation therapy. The measurements consisted of a thallium-201 retention index; the details of this technique are described in their articles. Nagamachi et al (3) found that the pretreatment retention index was predictive of response to radiation therapy. A high retention index was predictive of ≥50% reduction in size of the primary site (complete or partial response), whereas a low retention index was predictive of <50% response (3). We have recently evaluated the ability of combined pre- and post-thallium-201 to predict response in squamous cell carcinoma of the head and neck treated with nonsurgical organ preservation therapy (4). Our preliminary results showed that persistence of activity in the primary site at 6 weeks after completion of therapy was indicative of persistent tumor, whereas loss of uptake was indicative of local control (4). We did not, however, quantify the pretreatment thallium uptake of the tumors in this report (4). This is something we can certainly consider investigating in future studies to shed more light on the insightful inquiry presented by Drs. O’Tuama and Poussaint.

References

  1. ↵
    Mukherji SK, Gapany M, Phillips D, et al. Thallium-201 single-photon emission CT versus CT for the detection of recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 1999;20:1215–1220
  2. ↵
    Nagamachi S, Hoshi H, Jinnouchi S, et al. 201TL SPECT for evaluating head and neck cancer. Ann Nucl Med 1996;10:105–111
    PubMed
  3. ↵
    Nagamachi S, Jinnouchi S, Flores LG, et al. The use of 201T1 SPET to predict the response to radiotherapy in patients with head and neck cancer. Nucl Med Commun 1996;17:935–942
    PubMed
  4. ↵
    Mukherji SK, Gapany M, Neelon B, McCartney W. Evaluation of 201T1 SPECT for predicting early treatment response in patients with squamous cell carcinoma of the extracranial head and neck treated with nonsurgical organ preservation therapy: initial results. J Comput Assist Tomogr 2000;24:146–151
    PubMed
  • American Society of Neuroradiology
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 23 (1)
American Journal of Neuroradiology
Vol. 23, Issue 1
1 Jan 2002
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Thallium-201 Single-Photon Emission CT in Recurrent Squamous Cell Carcinoma of the Head and Neck
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Thallium-201 Single-Photon Emission CT in Recurrent Squamous Cell Carcinoma of the Head and Neck
Lorcan A. O’Tuama, Tina Young Poussaint
American Journal of Neuroradiology Jan 2002, 23 (1) 174-175;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Thallium-201 Single-Photon Emission CT in Recurrent Squamous Cell Carcinoma of the Head and Neck
Lorcan A. O’Tuama, Tina Young Poussaint
American Journal of Neuroradiology Jan 2002, 23 (1) 174-175;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
    • References
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Acute Stroke Imaging in Transfer Patients Who Received Recent Intravenous Iodinated Contrast at an Outside Facility: An Unrecognized Problem That Deserves More Attention
  • Primary Angiitis of the CNS with Unremarkable Vessel Wall MR Imaging: How the “T1 Shinethrough” Effect on SWI Adds to the Detection of Gadolinium Enhancement of Small Intraparenchymal Brain Vessels
  • Reply:
Show more LETTER

Similar Articles

Advertisement

News and Updates

  • Lucien Levy Best Research Article Award
  • Thanks to our 2020 Distinguished Reviewers
  • Press Releases

Resources

  • Evidence-Based Medicine Level Guide
  • How to Participate in a Tweet Chat
  • AJNR Podcast Archive
  • Ideas for Publicizing Your Research
  • Librarian Resources
  • Terms and Conditions

Opportunities

  • Share Your Art in Perspectives
  • Get Peer Review Credit from Publons
  • Moderate a Tweet Chat

American Society of Neuroradiology

  • Neurographics
  • ASNR Annual Meeting
  • Fellowship Portal
  • Position Statements

© 2021 by the American Society of Neuroradiology | Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire